Reference material for PSA: The IFCC standardization study

Clinical Biochemistry

Volumn 31, Issue 6, 1998, Pages 475-481

  Stamey, Thomas A ^a   Chen, Zuxiong ^a   Prestigiacomo, Anthony F ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANALYTIC METHOD; CALIBRATION; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE MARKER; HUMAN; IMMUNOASSAY; LABORATORY DIAGNOSIS; MASS SCREENING; PRIORITY JOURNAL; PROSTATE CANCER; SAMPLING; STANDARD;

CHEMISTRY, CLINICAL; HUMANS; IMMUNOASSAY; LABORATORY TECHNIQUES AND PROCEDURES; MALE; ORGANIZATIONS; PROSTATE-SPECIFIC ANTIGEN; REFERENCE STANDARDS;

EID: 0032146613     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(98)00055-1     Document Type: Conference Paper

References (15)

1. 1. DeAntoni EP, Crawford ED. Prostate cancer awareness week: Education, service, and research in a community setting. Cancer (Suppl) 1995; 75: 1874-9.
2. 2. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994; 151: 1283-90.
3. 3. Stamey TA, Donaldson AN, Yemoto CE, McNeal JE, Sözen S, Gill H. Histological and clinical findings in 896 consecutive prostates treated only by radical retropubic prostatectomy from 1988 to 1997: epidemiologic significance of annual changes. J Urol 1998; Accepted.
4. 4. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid H-P. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer (Suppl) 1993; 71: 933-8.
5. 5. Stamey TA. Some comments on progress in the standardization of immunoassays for prostate-specific antigen. Br J Urol (Suppl 1) 1997; 79: 49-52.
6. 6. Stamey TA. Progress in standardization of immunoassays for prostate-specific antigen. Urol Clin N America 1997; 24(2): 269-73.
7. 7. Sensabaugh GF, Blake ET. Seminal plasma protein p30: simplified purification and evidence for identity with prostate-specific antigen. J Urol 1990; 144: 1523-6.
8. 8. Brehm SP, Hoch SO, Hoch JA. The isolation and identification of 1-antichymotrypsin as a DNA-binding protein from human serum. Biochem Biophys Res Comm 1980; 95: 1737-42.
9. 9. Bélanger A, van Halbeek H, Graves HCB, et al. Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard. Prostate 1995; 27: 187-97.
10. 10. Stamey TA, Teplow DB, Graves HCB. Identity of PSA purified from seminal fluid by different methods: comparison by amino acid analysis and assigned extinction coefficients. Prostate 1995; 27: 198-203.
11. 11. Chen Z, Prestigiacomo A, Stamey TA. Purification and characterization of prostate specific antigen complexed to alpha-1-antichymotrypsin as a reference material for international standardization of PSA immunoassays. Clin Chem 1995; 41(9): 1273-82.
12. 12. Stamey TA, Chen Z, Prestigiacomo AF. Serum prostate specific antigen binding 1-antichymotrypsin: influence of cancer volume, location and therapeutic selection of resistant clones. J Urol 1994; 152: 1510-4.
13. 13. Stamey TA. Second Stanford Conference on International Standardization of Prostate-Specific Antigen Immunoassays: September 1 and 2, 1994. Urology 1995; 45: 173-84.
14. 14. Primary Reference Preparations Used to Standardize Calibration of Immunochemical Assays for Serum Prostate Specific Antigen (PSA); Approved Guideline. I/LA19-A June 1997; Vol. 17 No. 6.
15. 15. Rapp J, Salle J, Dowell B, Weigand RA. Use of the Stanford 90:10 reference PSA to standardize the Ax-SYM free and total PSA assays [Abstract P-13]. J Intl Society Oncodevelopmental Biology & Medicine R&D 1997; July: 8.